Factors associated with microalbuminuria in Type 1 diabetes mellitus: A cross-sectional study

Diabetes Research and Clinical Practice

Volumn 48, Issue 1, 2000, Pages 43-49

  Campos Pastor, M M ^a   Escobar Jimenez F ^a   Mezquita, P ^a   Herrera Pombo, J L ^b   Hawkins Carranza, F ^c   Luna, J D ^a   Azriel, S ^b   Serraclara, A ^c   Rigopoulos, M ^c  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Diabetic nephropathy; Familial hypertension; Familial nephropathy

Indexed keywords

ADULT; ARTICLE; DIABETIC NEPHROPATHY; DISEASE PREDISPOSITION; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; HEREDITARY HYPERTENSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; RISK FACTOR; SPAIN;

ALBUMINURIA; ANALYSIS OF VARIANCE; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; PREVALENCE; REGRESSION ANALYSIS; SMOKING; SPAIN;

EID: 0342614996     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00133-3     Document Type: Article

References (31)

1. Krolewski A.S., Warram J.H., Rand L.I., Kahn C.R. Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications. N. Engl. J. Med. 317:1987;1390-1398.
2. Hostetter T.H. Mechanisms of diabetic nephropathy. Am. J. Kidney Dis. 23:1994;188-192.
3. Trevisan R., Viberti G.C. Genetic factors in the development of diabetic nephropathy. J. Lab. Clin. Med. 126:1995;342-349.
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:1993;977-986.
5. Krolewski A.S., Laffel L.M.B., Krolewski M., Quinn M., Warram J.H. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N. Engl. J. Med. 332:1995;1251-1255.
6. Mühlhauser I. Smoking and diabetes. Diabetic Med. 7:1990;10-15.
7. Sawicki P., Didfurgeit U., Mühlhauser I., Bender R., Heinemann L., Berger M. Smoking is associated with progression of diabetic nephropathy. Diabetes Care. 17:1994;126-131.
8. Mulec H., Johnsen S.A., Wiklund O., Bjorck S. Cholesterol. A renal risk factor in diabetic nephropathy? Am. J. Kidney Dis. 22:1993;196-201.
9. Krolewski A.S., Warram J.H., Christlieb A.R. Hypercholesterolemia. A determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int. 45:1994;125-131.
10. World Health Organization Study Group, Diabetes Mellitus, World Health Organization technical report series, 1985, No. 727, Geneve.
11. Chowdhury T.A., Kumar S., Barnett A.H., Bain S.C. Nephropathy in Type 1 diabetes. The role of genetic factors. Diabetic Med. 12:1995;1059-1067.
12. Quinn M., Angélico M.C., Warram J.H., Krolewski A.S. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 39:1996;940-945.
13. Seaquist E.R., Goetz F.C., Rich S., Barbosa J. Familial clustering of diabetic kidney disease. N. Engl. J. Med. 320:1989;1161-1165.
14. McCance D.R., Hanson R.L., Pettitt D.J., Jacobsson L.T., Bennett P.H., Bishop D.T., Knowler W.C. Diabetic nephropathy: a risk factor for diabetes mellitus in offspring. Diabetologia. 38:1995;221-226.
15. Faronato P.P., Maioli M., Tanolo G., Brocco E., Noventa F., Piarulli F., Abaterusso C., Modena F., de Bigontina G., Velussi M., Inchiostro S., Santeusanio F., Bueti A., Nosadini R. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. Diabetologia. 40:1997;816-823.
16. Viberti G.C., Keen H., Wiseman M.J. Raised arterial pressure in parents of proteinuria insulin-dependent diabetics. Br. Med. J. 295:1987;515-517.
17. Krolewski A.S., Canessa M., Warram J.H., Laffel L.M., Christlieb A.R., Knowler W.C., Rand L.I. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N. Engl. J. Med. 318:1988;140-145.
18. Earle K., Walker J.D., Hill C., Viberti G.C. Familial clustering of cardiovascular disease in insulin-dependent diabetic patients with nephropathy. N. Engl. J. Med. 326:1992;673-677.
19. Norgaard K., Mathiesen E.R., Hommel E., Jensen J.S., Parving H.H. Lack of familial predisposition to cardiovascular disease in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia. 34:1991;370-372.
20. De Cosmo S., Bacci S., Piras G.P., Cignarelli M., Placentino G., Margaglione M., Colaizzo D., Di Minno G., Giorgino R., Liuzzi A., Viberti G.C. High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia. 40:1997;1191-1196.
21. Canessa M., Andragna N., Solomon H.S., Connolly T.M., Tosteson D.C. Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N. Engl. J. Med. 302:1980;772-776.
22. Jones S.L., Trevisan R., Tariq T., Semplicini A., Mattock M., Walker J.D., Nosadini R., Viberti G. Sodium-lithium countertransport in microalbuminuric insulin-dependent diabetic patients. Hypertension. 15:1990;570-575.
23. Monciotti C.G., Semplicini A., Morocutti A., Maioli M., Cipollina M.R., Barzon I., Palaro C., Brocco E., Trevisan M., Fioretto P., Crepaldi G., Nosadini R. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM. Diabetologia. 40:1997;654-661.
24. Walker J.D., Tariq T., Viberti G.C. Sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy and their parents. Br. Med. J. 301:1990;635-638.
25. Catalano C., Winocour P.H., Thomas T.H., Walker M., Sum C.F., Wilkinson R., Alberti K.G. Erythrocyte sodium-lithium countertransport activity and total body insulin-mediated glucose disposal in normoalbuminuric normotensive type1 (insulin-dependent) diabetic patients. Diabetologia. 36:1993;52-56.
26. Stephenson J., Fuller J.H. Microvascular and acute complications in IDDM patients: the EURODIAB complications study. Diabetologia. 37:1994;278-285.
27. Bennett P.H., Haffner S., Kasiske B.L., Keane W.F., Mogensen C.E., Parving H.H., Steffes M.W., Striker G.E. Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the council on Diabetes Mellitus of the National Kidney Foundation. Am. J. Kidney Dis. 25(1):1995;107-112.
28. Viberti C.G., Mogensen C.E., Groop L.C., Pauls J.F. Effects of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. J. Am. Med. Assoc. 26:1994;275-279.
29. Consensus statement. American Diabetes Association. Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus, Diabetes Care 17 (1994) 1357-1361.
30. Mogensen C.E., Keane W.F., Bennett P.H., Jerums G., Parving H.H., Passa P., Steffes M.W., Striker G.E., Viberti G.C. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet. 346:1995;1080-1084.
31. Parving H.H., Hommel E., Mathiensen E., Skott P., Edsberg B., Bahnsen M., Lauritzen M., Hougaard P., Lauritzen E. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br. Med. J. 295:1988;156-160.